0 Views
0 Likes
0 Shares
0 Comments
Read article ↗

StayCurrentMD

View profile →

Article

The Risk of Necrotizing Enterocolitis following the Administration of Hyperosmolar Enteral Medications to Extremely Preterm Infants

Published: Reading: 1 min

Topic overview

Retrospective cohort study of 253 extremely preterm infants found that while 94% received hyperosmolar enteral medications exceeding AAP guidelines (>450 mOsm/kg), no significant increased risk of necrotizing enterocolitis was observed. Further research needed to establish safe osmolality thresholds.

Keywords

Necrotizing Enterocolitis Extremely Preterm Infants Hyperosmolar Medications Enteral Administration Neonatal Intensive Care Medication Osmolality

Hashtags

#NeonatalCare #PretermInfants #NEC #NICU

Full article text

Full article text not available for this entry
How to cite: GlobalCastMD. The Risk of Necrotizing Enterocolitis following the Administration of Hyperosmolar Enteral Medications to Extremely Preterm Infants. GlobalCastMD Medical Library. 2021-04-14. https://library.globalcastmd.com/article/3923

Comments

Loading comments...